trans-2-(4-Hydroxy-cyclohexyl)-isoindole-1,3-dione, 95.0%, 1g

2-Chloro-5-(trifluoromethyl)pyridin-4-amine, 95.0%, 10g

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with ethyl (2R,3S)-2-[4-(cyclopentylamino)phenyl]-3-piperidinecarboxylate (2:1), 97%, 1g

N-Boc-3-Iodomethyl-pyrrolidine, 95.0%, 5g

2-(2-(Bromomethyl)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

(2-Nitro-4-trifluoromethyl-phenyl)-hydrazine, 95.0%, 1g

(2-Chloro-5-methoxypyridin-4-yl)boronic acid, 97%, 25g

Ethyl 5-amino-2,6-dichloropyrimidine-4-carboxylate, 95.0%, 25g

3-amino-1H-1,2,4-triazole-5-carboxamide, 95.0%, 5g

2-Bromo-5-fluorophenylacetic acid, 98.0%, 10g

3-((E)-3-Phenyl-2-propenoyl)-1,3-oxazolidin-2-one, 97%, 1g

5-Chloro-2-formylbenzonitrile, 95.0%, 1g

5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 97%, 10g